3,4-Diaminopyridine as a treatment for amyotrophic lateral sclerosis
- 31 March 1995
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 129 (1) , 21-24
- https://doi.org/10.1016/0022-510x(94)00225-d
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The effects of 4‐aminopyridine in multiple sclerosis patientsNeurology, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- A validation of the Functional Independence Measurement and its performance among rehabilitation inpatientsArchives of Physical Medicine and Rehabilitation, 1993
- Preliminary trial of 3,4‐diaminopyridine in patients with multiple sclerosisAnnals of Neurology, 1990
- A double‐blind, placebo‐controlled trial of high doses of gangliosides in amyotrophic lateral sclerosisNeurology, 1989
- Central motor conduction in motor neuron diseaseAnnals of Neurology, 1987
- Central motor conduction is abnormal in motor neuron disease.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.The Journal of Physiology, 1981
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960